Challenges and insights in immunization in patients with demyelinating diseases: a bench-to-bedside and evidence-based review

Challenges and insights in immunization in patients with demyelinating diseases: a bench-to-bedside and evidence-based review

ABSTRACT Background: Infections are among the main causes of death in patients with demyelinating diseases of the central nervous system (CNSDD). Vaccines are effective methods in reducing hospitalization and death from infectious diseases, but they are challenging in patients with CNSDD because o...

Full description

Bibliographic Details
Main Authors:	Guilherme Diogo Silva, Vítor Falcão de Oliveira, Leonardo Oliveira Mendonça
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO) 2022-08-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	Vaccines Demyelinating Diseases Multiple Sclerosis Immunization Neuromyelitis Optica
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2022000700173&tlng=en

Similar Items

Demyelinating diseases of the central nervous system in children: lecture for practicing pediatricians
by: A. S. Kotov, et al.
Published: (2021-07-01)

Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
by: Mohammad Hossein Harirchian, et al.
Published: (2015-02-01)

Magnetic Resonance Imaging of Autoimmune Demyelinating Diseases as a Diagnostic Challenge for Radiologists: Report of Two Cases and Literature Review
by: Antonio Pierro, et al.
Published: (2022-03-01)

A CASE REPORT OF RARE FAMILIAL DEMYELINATING DISEASE
by: N.T. Dzhaparalieva, et al.
Published: (2023-06-01)

A CASE REPORT OF RARE FAMILIAL DEMYELINATING DISEASE
by: N.T. Dzhaparalieva, et al.
Published: (2023-06-01)

Acquired demyelinating disorders of central nervous system: A pediatric cohort
by: Sheffali Gulati, et al.
Published: (2015-01-01)

Pregnancy-Related Immune Changes and Demyelinating Diseases of the Central Nervous System
by: Ke Qiu, et al.
Published: (2019-10-01)

Clinical Evaluation of Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease- A Case Series
by: Rahul Gupta, et al.
Published: (2022-03-01)

Editorial: Neuropathology of Autoimmune Inflammatory Demyelination Disorders
by: Manuel Zeitelhofer, et al.
Published: (2022-06-01)

Auto antibodies in inflammatory demyelinating diseases of the central nervous system
by: Swiss Medical Weekly
Published: (2008-11-01)

Demyelinating syndrome in systemic sclerosis and neuromyelitis optica
by: Khaled Deeb, et al.
Published: (2019-10-01)

Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach
by: Ana Beatriz Ayroza Galvão Ribeiro Gomes, et al.
Published: (2022-10-01)

Spinal dystonia and other spinal movement disorders
by: Shlok Sarin, et al.
Published: (2023-08-01)

Efficacy and safety of rituximab in central nervous system demyelinating disorders
by: Varsha A Patil, et al.
Published: (2021-01-01)

The Role of Extracellular Vesicles in Demyelination of the Central Nervous System
by: José Antonio López-Guerrero, et al.
Published: (2020-11-01)

Genetic Basis of Inflammatory Demyelinating Diseases of the Central Nervous System: Multiple Sclerosis and Neuromyelitis Optica Spectrum
by: Genaro Gabriel Ortiz, et al.
Published: (2023-06-01)

Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases
by: Zhou Ran, et al.
Published: (2020-08-01)

MRI features of myelin oligodendrocyte glycoprotein antibody disease: a descriptive study—how it differs from neuromyelitis optica spectrum disorders and multiple sclerosis
by: J. Tom Mishael, et al.
Published: (2023-07-01)

Differential diagnosis of demyelinating diseases: what's new?
by: Ana Beatriz Ayroza Galvão Ribeiro Gomes, et al.
Published: (2022-08-01)

Neuromyelitis Optica with NMO-IgG/ Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India
by: Manish Mittal, et al.
Published: (2014-07-01)

Editorial: Demyelinating neurological syndromes: The role of autoimmunity
by: Maria Eleftheria Evangelopoulos, et al.
Published: (2023-03-01)

Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system
by: Jefferson Becker, et al.
Published: (2021-11-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
by: Elia Sechi, et al.
Published: (2022-06-01)

Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome
by: Qiling Ji, et al.
Published: (2022-05-01)

Multi-parametric MRI phenotype with trustworthy machine learning for differentiating CNS demyelinating diseases
by: Jing Huang, et al.
Published: (2021-09-01)

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
by: Joseph A Lopez, et al.
Published: (2021-01-01)

TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder
by: Yun-Fan You, et al.
Published: (2023-04-01)

Optimizing the management of neuromyelitis optica and spectrum disorders in resource poor settings: Experience from the Mangalore demyelinating disease registry
by: Lekha Pandit, et al.
Published: (2013-01-01)

The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica
by: Milad Moayednia, et al.
Published: (2021-03-01)

Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease Pacientes com neuromielite óptica apresentam doença mais incapacitante que pacientes com esclerose múltipla, incluindo maior chance de falecerem de uma doença desmielinizante
by: Denis Bernardi Bichuetti, et al.
Published: (2013-05-01)

Jaw clonus in neuromyelitis optica spectrum disorder with subsequent osmotic demyelination syndrome
by: Ritwik Ghosh, et al.
Published: (2020-01-01)

Autoantibodies in central nervous system and neuromuscular autoimmune disorders: A narrative review
by: Mi Young Jeon, et al.
Published: (2022-06-01)

Case Report: Clinical and Imaging Characteristics of a Patient with Anti-flotillin Autoantibodies: Neuromyelitis Optica or Multiple Sclerosis?
by: Ke Shang, et al.
Published: (2021-12-01)

The association between cognition and gait disturbance in central nervous system demyelinating disorder with mild disability
by: Min Cheol Chang, et al.
Published: (2023-04-01)

Diagnostic value of NMO-IgG in demyelinating diseases of central nervous system
by: Xiao-min XU, et al.
Published: (2016-09-01)

Neuromyelitis optica - an update: 2007-2009
by: Jacob Anu
Published: (2009-01-01)

Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice
by: Nicolo’ Bruschi, et al.
Published: (2020-10-01)

Diagnostic challenge in children with an acquired demyelinating syndrome: an illustrative case report
by: Luciana Midaglia, et al.
Published: (2023-07-01)

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder—MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
by: Franca Wagner, et al.
Published: (2018-09-01)

Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
by: Jia Liu, et al.
Published: (2022-11-01)